Cloud computing poised for biopharma adoption

Japanese, Chinese and Indian firms weigh in on cloud computing.

Adoption of cloud computing is set to grow within the life sciences industries of Japan, China, and India.

These are among the key findings reported by Ovum, a global analyst and consulting company. The report found that pharmaceuticals and bio-tech industries within the three countries "had on average more intent to invest in cloud computing than those companies interviewed in the rest of the world."

Financial factor

To continue reading, register here to become an Insider. You'll get free access to premium content from CIO, Computerworld, CSO, InfoWorld, and Network World. See more Insider content or sign in.

Adoption of cloud computing is set to grow within the life sciences industries of Japan, China, and India.

These are among the key findings reported by Ovum, a global analyst and consulting company. The report found that pharmaceuticals and bio-tech industries within the three countries "had on average more intent to invest in cloud computing than those companies interviewed in the rest of the world."

Financial factor

Based on 50 interviews across the region, the analysis revealed that life sciences companies with more positive IT budget situations were more receptive to the idea of cloud computing.

"As we start to see IT budgetary pressure easing within life sciences across the region, Ovum expects the issue of cloud computing to come up more frequently."